Stem/$STEM
Stem shares are trading higher after the company announced its support for a major solar-plus-storage project.
4 hours ago·Lightyear AI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Stem
Stem Inc is a provider of energy storage systems. The company bundles third-party hardware with its proprietary Athena software to provide customers a turnkey solution. Stem sells its solutions to commercial and industrial customers as well as independent power producers and renewable developers. Its solutions help customers maximize renewable energy generation and help build a cleaner and more resilient grid. The Company operates as one operating segment that is focused exclusively on technology services that transform the way energy is distributed and consumed.
Ticker
$STEM
Sector
Trading on
NYSE
Industry
Electrical Equipment
Headquarters
Employees
569
ISIN
US85859N1028
Website
Stem Metrics
BasicAdvanced
$94M
-
-$4.95
1.43
-
Price and volume
Market cap
$94M
Beta
1.43
52-week high
$1.68
52-week low
$0.29
Average daily volume
4.3M
Financial strength
Current ratio
0.92
Quick ratio
0.776
Long term debt to equity
-138.194
Total debt to equity
-142.372
Interest coverage (TTM)
-6.50%
Management effectiveness
Return on assets (TTM)
-8.59%
Return on equity (TTM)
3,595.51%
Valuation
Price to revenue (TTM)
0.605
Price to book
-0.22
Price to tangible book (TTM)
-0.17
Price to free cash flow (TTM)
-2.334
Growth
Revenue change (TTM)
-63.86%
Earnings per share change (TTM)
361.23%
3-year revenue growth (CAGR)
-0.31%
3-year earnings per share growth (CAGR)
152.10%
What the Analysts think about Stem
Analyst ratings (Buy, Hold, Sell) for Stem stock.
Stem Financial Performance
Revenues and expenses
Stem Earnings Performance
Company profitability
Stem News
AllArticlesVideos
Stem Announces Support of One of Nation's Largest Solar-Plus-Storage Projects
Business Wire·6 days ago
Voltron Therapeutics, Inc., a Lucius Partners Portfolio Company, Announces Definitive Proof of Concept Data for its Second Oncology Candidate (VTX-0P4) in a Prostate Stem Cell Antigen (PSCA) Related Tumor Study in Combination with a Checkpoint Inhibitor (CPI) / anti-mPD-1
GlobeNewsWire·2 weeks ago
Stem Announces First Quarter 2025 Results Conference Call
Business Wire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Stem stock?
Stem (STEM) has a market cap of $94M as of June 09, 2025.
What is the P/E ratio for Stem stock?
The price to earnings (P/E) ratio for Stem (STEM) stock is 0 as of June 09, 2025.
Does Stem stock pay dividends?
No, Stem (STEM) stock does not pay dividends to its shareholders as of June 09, 2025.
When is the next Stem dividend payment date?
Stem (STEM) stock does not pay dividends to its shareholders.
What is the beta indicator for Stem?
Stem (STEM) has a beta rating of 1.43. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.